What property should be avoided in agents used for psychotic patients?

When considering the management of psychotic patients, it is crucial to avoid medications that possess anticholinergic properties. Anticholinergic agents can exacerbate certain side effects, particularly in the context of psychiatric treatments. Patients with psychosis may already be susceptible to cognitive impairment and other neurological side effects, and the introduction of anticholinergic properties can worsen these issues, leading to confusion, sedation, and decreased cognitive functioning.

Additionally, anticholinergic side effects can contribute to complications such as urinary retention, dry mouth, blurred vision, and constipation, which are particularly concerning in a vulnerable population. The goal in treating psychotic disorders is to use agents that minimize such risks while effectively managing the symptoms of the condition. Therefore, the avoidance of agents with significant anticholinergic effects is a fundamental consideration when selecting appropriate pharmacotherapy for individuals with psychotic disorders.